South Danish Obesity Initiative, Screening for Unrecognized Obesity Related Disease

ConditionObesity
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-60
SponsorClaus Bogh Juhl

About this trial

People with BMI \>30 kg/m2 will be included in at population-based cohort. Additionally, one control group with BMI 18.5-25 kg/m2 and one control group with BMI 25-30 kg/m2 will be included. All participants with age 18 and 60 years.

To evaluate health status participants will be screened by for undetected obesity-related diseases (hypertension, diabetes, dyslipidemia, sleep apnea, non-alcoholic fatty liver disease, chronic obstructive pulmonary disease, EKG-abnormalities, polycystic ovary syndrome (PCOS), and joint pain and for quality of life at baseline, 1 year, and 5 years. Additionally, anthropometric measurements are collected and a biobank is established for future research studies.

People with obesity related disease will be offered participation in a 12 month personalized lifestyle intervention program aimed at improvement of health and self-perception.

The collected data will be used to detect the prevalence for obesity-related disease to identify predictors for future obesity related disease and to evaluate the effect of a lifestyle intervention on health and quality of life.

Eligibility criteria

Qualifiers

BMI >30 (Obese cohort), BMI 20-25 (control group I), BMI 25-30 (control group II)

Age 18-60 years

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Life style intervention (dietician+ physiotherapist)
  • Self management
  • No intervention

Treatment groups

2,700 Participants
are divided into 3 treatment groups

Sponsors and collaborators

Claus Bogh Juhl

Lead sponsor

Esbjerg Hospital - University Hospital of Southern Denmark

Sponsor institution

Steno Diabetes Center Odense

Collaborator

Odense University Hospital

Collaborator